Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mitec Technologies V.MTMH

"Mitec Technologies Inc exited the telecom and satellite communications area in 2012 and is exploring interesting opportunities in other areas."


TSXV:MTMH - Post by User

Post by birdie22on Oct 27, 2012 1:11pm
295 Views
Post# 20530885

COV. shades of MTM

COV. shades of MTM

COV. just did a pp for .052 cents Mandel bought 300,000 shares. I am wondering if MTM kicked in more money for part of the PP. Our .30 cent investment in COV. was just priced at .052 Cents.

This PP as far as I can find out was not pre announced !

Covalon Announces Closing of Non-Brokered Private Placement

 
17:10 EST Friday, Oct 26, 2012

MISSISSAUGA, ON, Oct. 26, 2012/CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced the closing of a non-brokered private placement comprised of 9.55 million units at a price of $0.052per unit for gross proceeds of $496,600. Each unit is comprised of one common share and one common share purchase warrant. Each common share purchase warrant entitles the holder to acquire an additional common share at a price of $0.10per share for a period of five years from the closing date. All securities issued pursuant to the Offering will be subject to a hold period expiring February 27, 2013. Directors and officers of Covalon participated in the non-brokered private placement for an aggregate of 1.8 million units. Proceeds of the private placement will be used by Covalon to develop and commercialize new wound care products,

 

<< Previous
Bullboard Posts
Next >>